Seaport Therapeutics (SPTX) Financials: Revenue & Earnings
SPTX$20.51-0.77 -3.62%
$1.10B
Market Cap
—
P/E
—
Forward P/E
—
Score
Seaport Therapeutics (SPTX) Financials: Revenue & Earnings
SPTX price $20.51 -0.77 -3.62%
- Ticker
- SPTX
- Price
- $20.51
- Change
- -0.77 -3.62%
- Market cap ?
- $1.10B
- Beta ?
- 1.13
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
SPTX fair value Not meaningful. Price $20.51.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-02 | — | -0.58 | — | — |
| 2026-08-03 | -1.78 | -0.62 | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-22 | HOMBACH ROBERT J. | Buy | 13.00K | $18.14 | 235.77K |
| 2026-05-04 | PureTech Health plc | Buy | 965.25K | — | — |
| 2026-05-04 | PureTech Health plc | Buy | 2.68M | — | — |
| 2026-05-04 | PureTech Health plc | Buy | 12.74M | — | — |
| 2026-05-04 | PureTech Health plc | Sell | 8.42M | — | — |
| 2026-05-04 | PureTech Health plc | Sell | 40.00M | — | — |
| 2026-05-04 | PureTech Health plc | Sell | 3.03M | — | — |
| 2026-04-30 | PureTech Health plc | Other | 0 | — | — |
| 2026-04-30 | PureTech Health plc | Other | 12.74M | — | — |
| 2026-04-30 | PureTech Health plc | Other | 2.68M | — | — |
| 2026-04-30 | PureTech Health plc | Other | 965.25K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 56. Ownership 70.19%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| ARCH VENTURE MANAGEMENT, LLC | 6.29M | New | New | 136.60M |
| GENERAL ATLANTIC, L.P. | 6.10M | New | New | 132.53M |
| SOFINNOVA INVESTMENTS, INC. | 3.56M | New | New | 77.43M |
| GOLDMAN SACHS GROUP INC | 2.18M | New | New | 47.32M |
| TRV GP VI, LLC | 2.06M | New | New | 44.77M |
| CANADA PENSION PLAN INVESTMENT BOARD | 1.98M | New | New | 42.91M |
| JPMORGAN CHASE & CO | 1.82M | New | New | 40.89M |
| FORESITE CAPITAL MANAGEMENT VI LLC | 1.78M | New | New | 38.65M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.31M | New | New | 28.42M |
| FMR LLC | 1.19M | New | New | 25.74M |
| BELLEVUE GROUP AG | 1.10M | New | New | 23.89M |
| SIREN, L.L.C. | 1.10M | New | New | 23.79M |
| JENNISON ASSOCIATES LLC | 1.08M | New | New | 23.45M |
| RA CAPITAL MANAGEMENT, L.P. | 700.00K | New | New | 15.20M |
| VANGUARD CAPITAL MANAGEMENT LLC | 599.22K | New | New | 13.01M |
| WOODLINE PARTNERS LP | 586.35K | New | New | 12.74M |
| PERCEPTIVE ADVISORS LLC | 500.00K | New | New | 10.86M |
| BRAIDWELL LP | 500.00K | New | New | 10.86M |
| PRINCIPAL FINANCIAL GROUP INC | 414.67K | New | New | 9.01M |
| ABERDEEN GROUP PLC | 310.36K | New | New | 6.74M |
| UBS GROUP AG | 279.18K | New | New | 6.06M |
| BLACKROCK, INC. | 229.86K | New | New | 4.99M |
| SEVEN GRAND MANAGERS, LLC | 225.00K | New | New | 4.89M |
| CITADEL ADVISORS LLC | 191.14K | New | New | 4.15M |
| GEODE CAPITAL MANAGEMENT, LLC | 175.87K | New | New | 3.82M |
Earnings and financials
Seaport Therapeutics, Inc. Common Stock (SPTX) trades at $20.51, with a market cap of $1.10B and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn